Roland L. Bassett

Roland L. Bassett is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on oncology, with specific interests in breast cancer treatment, radiation oncology, immunotherapy, and hematology. His recent work includes investigating neoadjuvant sacituzumab govitecan combined with pembrolizumab for early-stage triple-negative breast cancer, adjuvant PD-1 blockade with endocrine therapy for inflammatory breast cancer, and clinical outcomes of GLP1 receptor agonists in breast cancer survivors. He has also published on venous thromboembolism in multiple myeloma patients treated with daratumumab and diagnostic accuracy of dermoscopic features in acral lentiginous melanoma. His research integrates clinical trials, biomarkers, and molecular correlates to advance cancer care.